XML 86 R74.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidating Financial Information - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Mar. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Debt Instrument [Line Items]              
Decrease in total assets $ (17,646,000,000)   $ (17,646,000,000)     $ (16,511,000,000)  
Decrease in total liabilities (12,501,000,000)   (12,501,000,000)     (11,786,000,000)  
Decrease in total shareholders' equity (5,145,000,000) $ (4,408,000,000) (5,145,000,000) $ (4,408,000,000)   (4,725,000,000) $ (4,142,000,000)
Net income 147,000,000 202,000,000 313,000,000 386,000,000      
Net Sales 3,686,000,000 3,879,000,000 7,385,000,000 7,570,000,000      
Cost of goods sold 2,792,000,000 2,813,000,000 5,557,000,000 5,514,000,000      
8.75% due 2020 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount $ 282,000,000   $ 282,000,000        
Interest rate, stated percentage 8.75%   8.75%        
5.125% due 2023 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount $ 1,000,000,000   $ 1,000,000,000        
Interest rate, stated percentage 5.125%   5.125%        
5% due 2026 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount $ 900,000,000   $ 900,000,000        
Interest rate, stated percentage 5.00%   5.00%        
4.875% due 2027 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount $ 700,000,000   $ 700,000,000   $ 700,000,000    
Interest rate, stated percentage 4.875%   4.875%   4.875%    
Reportable Legal Entities | Parent Company              
Debt Instrument [Line Items]              
Decrease in total assets $ (11,870,000,000)   $ (11,870,000,000)     (11,477,000,000)  
Decrease in total liabilities (6,961,000,000)   (6,961,000,000)     (6,970,000,000)  
Decrease in total shareholders' equity (4,909,000,000)   (4,909,000,000)     (4,507,000,000)  
Net income 147,000,000 202,000,000 313,000,000 386,000,000      
Net Sales 1,863,000,000 1,889,000,000 3,630,000,000 3,676,000,000      
Cost of goods sold 1,462,000,000 1,407,000,000 2,842,000,000 2,737,000,000      
Reportable Legal Entities | Parent Company | Restatement Adjustment              
Debt Instrument [Line Items]              
Decrease in total assets           113,000,000  
Decrease in total liabilities           113,000,000  
Reportable Legal Entities | Guarantor Subsidiaries              
Debt Instrument [Line Items]              
Decrease in total assets (1,461,000,000)   (1,461,000,000)     (1,399,000,000)  
Decrease in total liabilities (286,000,000)   (286,000,000)     (268,000,000)  
Decrease in total shareholders' equity (1,175,000,000)   (1,175,000,000)     (1,131,000,000)  
Net income 12,000,000 6,000,000 36,000,000 34,000,000      
Net Sales 290,000,000 351,000,000 589,000,000 665,000,000      
Cost of goods sold 286,000,000 329,000,000 560,000,000 624,000,000      
Reportable Legal Entities | Guarantor Subsidiaries | Restatement Adjustment              
Debt Instrument [Line Items]              
Decrease in total assets           358,000,000  
Decrease in total liabilities           46,000,000  
Decrease in total shareholders' equity           312,000,000  
Net income   2,000,000   8,000,000      
Reportable Legal Entities | Non-Guarantor Subsidiaries              
Debt Instrument [Line Items]              
Decrease in total assets (9,895,000,000)   (9,895,000,000)     (8,989,000,000)  
Decrease in total liabilities (5,683,000,000)   (5,683,000,000)     (5,097,000,000)  
Decrease in total shareholders' equity (4,212,000,000)   (4,212,000,000)     (3,892,000,000)  
Net income 85,000,000 112,000,000 192,000,000 201,000,000      
Net Sales 2,316,000,000 2,347,000,000 4,618,000,000 4,603,000,000      
Cost of goods sold 1,842,000,000 1,797,000,000 3,638,000,000 3,574,000,000      
Reportable Legal Entities | Non-Guarantor Subsidiaries | Restatement Adjustment              
Debt Instrument [Line Items]              
Net Sales   322,000,000   614,000,000      
Cost of goods sold   322,000,000   614,000,000      
Consolidating Entries and Eliminations              
Debt Instrument [Line Items]              
Decrease in total assets 5,580,000,000   5,580,000,000     5,354,000,000  
Decrease in total liabilities 429,000,000   429,000,000     549,000,000  
Decrease in total shareholders' equity 5,151,000,000   5,151,000,000     $ 4,805,000,000  
Net income (97,000,000) (118,000,000) (228,000,000) (235,000,000)      
Net Sales (783,000,000) (708,000,000) (1,452,000,000) (1,374,000,000)      
Cost of goods sold $ (798,000,000) (720,000,000) $ (1,483,000,000) (1,421,000,000)      
Consolidating Entries and Eliminations | Restatement Adjustment              
Debt Instrument [Line Items]              
Net Sales   (322,000,000)   (614,000,000)      
Cost of goods sold   $ (322,000,000)   $ (614,000,000)